<?xml version="1.0" encoding="UTF-8"?>
<p>To test the efficacy of the VIRRION platform, we used a low pathogenic avian influenza A virus (LPAIV), which is an RNA virus (
 <xref ref-type="fig" rid="fig04">Fig. 4
  <italic>A</italic>
 </xref>). The average size of the H5N2 LPAIV is 101 Â± 11.7 nm, measured by transmission electron microscopy (TEM) (
 <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1910113117/-/DCSupplemental" xlink:show="new" xmlns:xlink="http://www.w3.org/1999/xlink">
  <italic>SI Appendix</italic>, Fig. S5
  <italic>A</italic>
 </ext-link>). We assembled a VIRRION with an ITD of 100 nm to match the average size of the AIV. We manually pushed 5 mL of the supernatant from virus culture through a syringe containing 10
 <sup>4</sup> EID
 <sub>50</sub>/mL (50% egg infective dose per microliter) H5N2 into a VIRRION. We then performed an immunofluorescence assay on the VIRRION to detect the captured AIV in situ by using an AIV H5 subtype-specific monoclonal antibody. Strong fluorescent signals were detected on the CNxCNT arrays (
 <xref ref-type="fig" rid="fig01">Fig. 1
  <italic>B</italic>
 </xref>), while no fluorescence was detected on the VIRRION when processing control samples that did not have H5N2 (
 <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1910113117/-/DCSupplemental" xlink:show="new" xmlns:xlink="http://www.w3.org/1999/xlink">
  <italic>SI Appendix</italic>, Fig. S5
  <italic>B</italic>
 </ext-link>). Under SEM and TEM, we clearly observed virus particles captured (
 <xref ref-type="fig" rid="fig01">Figs. 1
  <italic>A</italic>
 </xref> and 
 <xref ref-type="fig" rid="fig04">4
  <italic>B</italic>
 </xref>).
</p>
